mRNA expression of BRCA1, PIAS1, and PIAS4 and survival after second-line docetaxel in advanced gastric cancer.
作者:
主题词
腺癌(Adenocarcinoma);腺癌, 黏液(Adenocarcinoma, Mucinous);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);BRCA1蛋白质(BRCA1 Protein);癌(Carcinoma);癌, 腺鳞状(Carcinoma, Adenosquamous);癌, 印戒细胞(Carcinoma, Signet Ring Cell);癌, 鳞状细胞(Carcinoma, Squamous Cell);化学疗法, 辅助(Chemotherapy, Adjuvant);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);比值比(Odds Ratio);活化STAT的蛋白抑制物(Protein Inhibitors of Activated STAT);RNA, 信使(RNA, Messenger);回顾性研究(Retrospective Studies);小泛素相关修饰蛋白质类(Small Ubiquitin-Related Modifier Proteins);胃肿瘤(Stomach Neoplasms);紫杉烷类(Taxoids)
DOI
10.1093/jnci/djr326
PMID
21862729
发布时间
2018-12-01
- 浏览49
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文